Gattex Approval History
- FDA approved: Yes (First approved December 21st, 2012)
- Brand name: Gattex
- Generic name: teduglutide
- Company: NPS Pharmaceuticals, Inc.
- Treatment for: Short Bowel Syndrome
Gattex (teduglutide) is a recombinant analog of human glucagon-like peptide 2 for the treatment of adults with short bowel syndrome.
FDA Approval History for Gattex
|Dec 21, 2012|| FDA Approves Gattex to Treat Short Bowel Syndrome|
|Oct 16, 2012||FDA Advisory Committee Unanimously Recommends Approval of Gattex (teduglutide) for Adults with Short Bowel Syndrome (SBS)|
|Oct 12, 2012||FDA Posts Briefing Documents for Advisory Committee Meeting Reviewing Gattex (teduglutide) for Adult Short Bowel Syndrome|
|Aug 21, 2012||NPS Pharmaceuticals Receives Notice from FDA of Advisory Committee Meeting for Gattex (teduglutide)|
|Aug 13, 2012||NPS Pharmaceuticals Announces Extension of Action Date for Gattex NDA to December 30, 2012|
|Jan 31, 2012||NPS Pharmaceuticals Announces FDA Acceptance of New Drug Application for Gattex (teduglutide) for the Treatment of Adult Short Bowel Syndrome (SBS)|
|Dec 1, 2011||NPS Pharmaceuticals Completes Submission of New Drug Application for Gattex (teduglutide) in Adult Short Bowel Syndrome (SBS)|
|Aug 18, 2011||NPS Pharmaceuticals Submits Chemistry, Manufacturing and Controls (CMC) Section of New Drug Application for Gattex|
Gattex (teduglutide) Consumer Information
Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.